PTC Therapeutics

Promising gene therapy delivers treatment directly to brain
Stat
Tue, 01/24/23 - 06:11 pm
gene therapy
brain
drug delivery
PTC Therapeutics
Huntington's Disease Continues to Baffle Biopharma
BioSpace
Thu, 11/17/22 - 11:28 pm
Huntington's disease
Triplet Therapeutics
PTC Therapeutics
Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases
BioSpace
Mon, 11/7/22 - 10:52 am
neurodegenerative disease
Biogen
BioAge Labs
PTC Therapeutics
PTC Ready to Take Another Shot at FDA Approval of DMD Drug
BioSpace
Tue, 06/21/22 - 10:58 am
PTC Therapeutics
Translarna
FDA
Duchenne Muscular Dystrophy
Roche puts pressure on SMA rivals with new FDA approval
Pharmaforum
Tue, 05/31/22 - 10:33 am
Roche
PTC Therapeutics
SMA
Evrysdi
FDA
PTC aims again for FDA review of Duchenne drug despite latest miss
BioPharma Dive
Sat, 02/6/21 - 11:10 pm
PTC Therapeutics
Translarna
Duchenne Muscular Dystrophy
FDA
PTC Therapeutics taps experimental cancer drug for new COVID-19 trial
Fierce Biotech
Wed, 06/17/20 - 10:32 am
PTC Therapeutics
clinical trials
COVID-19
PTC29
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
Beckers Hospital Review
Thu, 06/11/20 - 10:46 pm
OptumRx
Roche
PTC Therapeutics
risdiplam
SMA
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Immunomedics
Trodelvy
triple negative breast cancer
Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song
Endpoints
Thu, 05/7/20 - 10:42 am
PTC Therapeutics
Censa Pharmaceuticals
PKU
M&A
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
Wed, 11/27/19 - 12:36 pm
gene therapy
drug manufacturing
Pfizer
Novartis
Bluebird Bio
PTC Therapeutics
Krystal Biotech
Roche, PTC will now get an FDA decision on their SMA drug in 6 months — facing off with Biogen, Novartis
Endpoints
Mon, 11/25/19 - 09:52 am
Roche
PTC Therapeutics
SMA
risdiplam
Biogen
Spinraza
What could help biotech close out 2019 stronger? Analysts pick 3 events to watch
Biopharma Dive
Sat, 09/7/19 - 06:38 pm
Amgen
AMG 510
KRAS inhibitors
Roche
PTC Therapeutics
risdiplam
Eylea
Novartis
Roche, PTC post latest SMA data from their attempt to rival Spinraza, Zolgensma
Fierce Biotech
Tue, 05/7/19 - 10:19 am
Roche
PTC Therapeutics
spinal muscular atrophy
risdiplam
Novartis
Zolgensma
Biogen
Spinraza
Nabbing late-stage drug, PTC acquires gene therapy startup Agilis for $200M in cash/stock
Endpoints
Thu, 07/19/18 - 11:23 pm
PTC Therapeutics
gene therapy
M&A
Agilis
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Motley Fool
Tue, 06/19/18 - 10:42 pm
PTC Therapeutics
risdiplam
Biogen
Ionis Pharmaceuticals
spinal muscular atrophy
Sarepta Therapeutics
Translarna
Emflaza
Did the FDA just leave the door cracked open for PTC’s Duchenne drug after repeated slapdowns?
Endpoints
Tue, 02/20/18 - 09:17 am
FDA
PTC Therapeutics
DMD
Duchenne Muscular Dystrophy
ataluren
The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time
Xconomy
Thu, 10/26/17 - 09:25 am
PTC Therapeutics
Duchenne Muscular Dystrophy
FDA
Translarna
FDA experts turn thumbs down on PTC’s wobbly case for its Duchenne MD drug
Endpoints
Fri, 09/29/17 - 09:42 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
ataluren
FDA pours cold water on PTC Therapeutics' Duchenne application
Reuters
Wed, 09/27/17 - 10:02 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
ataluren

Pages